Predictive biomarkers: a paradigm shift towards personalized cancer medicine.
about
DDX3, a potential target for cancer treatmentHow many molecular subtypes? Implications of the unique tumor principle in personalized medicineOn the Slow Diffusion of Point-of-Care Systems in Therapeutic Drug MonitoringHigh-Density Dielectrophoretic Microwell Array for Detection, Capture, and Single-Cell Analysis of Rare Tumor Cells in Peripheral BloodStathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancerBiomarkers to guide clinical therapeutics in rheumatology?Addressing human variability in next-generation human health risk assessments of environmental chemicalsImaging biomarker roadmap for cancer studiesPrognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trialA novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of rare tumor cells in blood.Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data.Glutathione S-conjugates as prodrugs to target drug-resistant tumors.Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study.Comparison of testing methods for the detection of BRAF V600E mutations in malignant melanoma: pre-approval validation study of the companion diagnostic test for vemurafenib.Mutations in the hedgehog pathway genes SMO and PTCH1 in human gastric tumorsContextualised urinary biomarker analysis facilitates diagnosis of paediatric obstructive sleep apnoeaThe Marker State Space (MSS) method for classifying clinical samples.Anaplastic lymphoma kinase (ALK) gene alteration in signet ring cell carcinoma of the gastrointestinal tract.Basal expression of insulin-like growth factor 1 receptor determines intrinsic resistance of cancer cells to a phosphatidylinositol 3-kinase inhibitor ZSTK474Commentary on Hey and KimmelmanDerivation of a fifteen gene prognostic panel for six cancers.Mathematical framework for activity-based cancer biomarkers.Drug repositioning for personalized medicine.Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma.A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion DiagnosticsPrognostic value of LIPC in non-small cell lung carcinoma.Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting.Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children's Oncology Group.Tissue banking, bioinformatics, and electronic medical records: the front-end requirements for personalized medicine.Targeting Negative Surface Charges of Cancer Cells by Multifunctional Nanoprobes.Beyond PSA: the next generation of prostate cancer biomarkers.Optimized Protocol for Quantitative Multiple Reaction Monitoring-Based Proteomic Analysis of Formalin-Fixed, Paraffin-Embedded Tissues.A new regulatory road-map for Alzheimer's disease drug developmentThe Impact of Receiving Predictive Genetic Information about Lynch Syndrome on Individual Colonoscopy and Smoking Behaviors.Therapeutic target database update 2014: a resource for targeted therapeutics.Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients.Identifying predictive markers for personalized treatment selection.Inhibiting the system xC-/glutathione axis selectively targets cancers with mutant-p53 accumulationRelevance of deep learning to facilitate the diagnosis of HER2 status in breast cancer.
P2860
Q26779054-192F8E0A-B1E9-4648-BE82-46D436243F73Q26992045-4EB4F86F-0C09-45DA-8776-3923B889B8D0Q27024074-386E29C4-F447-46C5-8D91-4B1A66A38395Q27304104-4B9B126F-0B44-49D1-9E38-5043914825BFQ27852937-0E8954C1-498A-4BDC-9527-927C3E59E148Q28080053-6B5E96B6-5963-4BE5-A6C7-C5E5483B15CCQ28393541-5ED01FBC-7C4E-47FB-9211-26174FBB2CD1Q30242020-26459DD7-D1BA-4693-854D-C0CF9BB37439Q30537414-268578BD-5670-44AC-A1B8-A548549DFAB2Q33741201-AD62D3DB-4BA7-4977-AF1C-F3B0740B677DQ33766729-2DAD3375-2F36-4D77-8F42-803D64F529EDQ34024771-4BB61EF7-08F3-4BE2-8BDE-F7158B971BCEQ34465123-A363355C-FB4B-4076-8E51-634B223ADDBCQ34551705-534FB68E-7BC9-4119-B51E-7DEBC9788B25Q34563073-D85E7248-B214-4D1C-A3B3-4996909C580EQ34586288-54A5BD3A-F41B-4136-9595-AFBF7DB0E8D8Q34764369-1501CB34-816D-42CB-8015-3FEBA518A405Q35136824-D2EBEED2-4C0B-441C-A72E-34FBAA3C9B92Q35439316-59369F0F-E514-4721-98EC-2DA8B194324CQ35820701-7E3EBBFF-C388-4B7C-B8C3-45D2C61308BCQ35953479-28F434A5-84A6-4978-93AE-977FC2EC8681Q36179245-40090275-E7B8-4879-AE0A-3BB9B24736B8Q36245193-64771A0B-2DF6-455D-8439-7A061AB5F137Q36392598-1D4543B4-F855-406C-8A2A-F5C0C465281FQ36414073-03EE39F7-F141-4239-AB9C-D8355B71B640Q36512012-66CF598B-BFA4-4828-87F5-2C449DD108FAQ36674309-684F3DBD-5064-495D-AF33-3FFE324AF8CBQ36747333-FB38F742-0EF4-4B23-BA5E-920ED7F8B7F5Q36907188-23624676-083F-494C-BFAB-2DDF13C197ECQ36931470-F93D7D1A-EA8A-46CD-94B0-C99F26C15445Q37202315-AF85E2FC-E0B2-43DE-B5C9-E8FE908118FFQ37238101-39D160AB-C596-422A-82D2-16AC655756DFQ37244491-1E7D1396-B7B5-414F-84C4-E26DC1634241Q37510270-4EC606FD-C17A-4814-9C34-6404EC1A61A5Q37611175-C5528D75-16FC-4889-BF79-BBD249B760A0Q37661746-F14B73C7-7463-4F46-B914-AADC49347432Q37672829-9A7A7147-0DFD-4F33-80C1-4EB0FD33E592Q37702844-7AAB0F99-6709-4FAF-BA1F-01AE641F4C9AQ37736385-9FBD81CD-3CE7-4505-BCDF-11DE6DBC7636Q37737882-52C7D50E-CBA4-4710-967E-2CC1E23AA8C9
P2860
Predictive biomarkers: a paradigm shift towards personalized cancer medicine.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Predictive biomarkers: a paradigm shift towards personalized cancer medicine.
@en
Predictive biomarkers: a paradigm shift towards personalized cancer medicine.
@nl
type
label
Predictive biomarkers: a paradigm shift towards personalized cancer medicine.
@en
Predictive biomarkers: a paradigm shift towards personalized cancer medicine.
@nl
prefLabel
Predictive biomarkers: a paradigm shift towards personalized cancer medicine.
@en
Predictive biomarkers: a paradigm shift towards personalized cancer medicine.
@nl
P1476
Predictive biomarkers: a paradigm shift towards personalized cancer medicine.
@en
P2093
David J Kerr
Nicholas B La Thangue
P304
P356
10.1038/NRCLINONC.2011.121
P407
P577
2011-08-23T00:00:00Z